GENE ONLINE|News &
Opinion
Blog

M&A
Indivior Buys Opiant For $145 Million, Adds Opioid Overdose Treatments To Portfolio
2022-11-15
Johnson & Johnson Throws Down $16.6 billion for Abiomed
2022-11-01
Thermo Fisher Announces the Multi-Billion Dollar Acquisition of The Binding Site Group
2022-10-31
AbbVie Buys DJS Antibodies For $255 Million To Beef Up Immunology Portfolio
2022-10-21
Eli Lilly Snatches Up Akouos Treating Ear Conditions for $487 million
2022-10-18
Novo Nordisk Finally Finalizes their Billion Dollar Acquisition of Forma Therapeutics
2022-10-14
Myovant Turns Down $2.4 Billion Buyout Bid From Sumitomo
2022-10-03
Alexion Snaps Up LogicBio Seeking Expansion into Genomic Medicines
2022-10-03
Roche Buys Good Therapeutics For $250 Million Upfront, Obtains Immune Stimulating Antibody Conjugate Program
2022-09-08
European Commission Prohibits Illumina’s Acquisition of GRAIL After The Company’s Win Against The FTC
2022-09-07
CVS Beats Amazon in Signify Bidding War with $8 Billion Acquisition Offer
2022-09-06
Novo Nordisk Seals the Deal On A $1.1 Billion Acquisition of Forma Therapeutics
2022-09-01
Novartis Split: Sandoz Spin Off Forming A Standalone Company
2022-08-25
Amazon Care Scrapped, Making Room for New Telehealth Endeavors
2022-08-25
Alcon Acquires Aerie For $770 Million, Adding Eye Drops To Portfolio
2022-08-24
1 2 3 4 5 6 14
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top